CLINICAL_TRIALS
trial_result
· 2020-09-09
Clinical Trial Update: A Pilot Trial of Clazakizumab in Late ABMR [Phase 2]
Summary
A Phase 2 pilot trial evaluating clazakizumab for antibody-mediated rejection has completed recruitment.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Medical University of Vienna | Conditions: Antibody-mediated Rejection | Phase 2 | Status: COMPLETED